Milestone Pharmaceuticals Inc. — Director's Dealing 2022

Oct 21, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2022-10-20

Reporting Person: Liebert Debra K. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-20	Common Shares	P	10000	$5.29	Acquired	10000	Indirect
2022-10-21	Common Shares	P	4000	$5.26	Acquired	4000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	127	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: These shares are held in a trust for the benefit of several including the Reporting Person's spouse. The Reporting Person's spouse is a co-executor of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.